Can ad hoc analyses of clinical trials help personalize treatment decisions?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Can ad hoc analyses of clinical trials help personalize treatment decisions?

Published:2017-08-16 Issue:11 Volume:83 Page:2337-2338
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Biltaji Eman¹²³,Kumar Shaun S.¹^ORCID,Enioutina Elena Y.¹⁴,Sherwin Catherine M. T.¹²^ORCID

Affiliation:

1. Division of Clinical Pharmacology, Department of Paediatrics; University of Utah, School of Medicine; Salt Lake City Utah USA

2. Department of Pharmacotherapy, College of Pharmacy; University of Utah; Salt Lake City Utah USA

3. Program in Personalized Health; University of Utah; Salt Lake City Utah USA

4. Department of Pathology; University of Utah, School of Medicine; Salt Lake City Utah USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.13377/fullpdf

Reference9 articles.

1. Weiss KD Approval letter for cetuximab 2004 https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/125084ltr.pdf

2. Cetuximab for the treatment of colorectal cancer;Jonker;N Engl J Med,2007

3. K-ras mutations and benefit from cetuximab in advanced colorectal cancer;Karapetis;N Engl J Med,2008

4. KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer;Massarelli;Clin Cancer Res,2007

5. KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib;Pao;PLoS Med,2005

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secondary Analysis of Individual Patient-Level Clinical Trial Data: A Primer;Access to Non-Summary Clinical Trial Data for Research Purposes Under EU Law;2021

2. Does cardiology hold pharmacogenetics to an inconsistent standard? A comparison of evidence among recommendations;Pharmacogenomics;2018-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3